Skip to main content

Advertisement

Table 5 Patient characteristics with impact on total cancer incidence

From: Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort

Variable HR 95%-CI
Female sex 0.69 [0.65-0.72]
BMI (≥ 30 kg/m2) 0.90 [0.86-0.95]
Diabetes duration more than 2 years 0.79 [0.73-0.86]
Metformin (only) 0.95 [0.90-1.01]
Insulin (including combination with metformin) 1.25 [1.17-1.33]
Analogues (including combination with insulin/metformin) 0.89 [0.79-1.01]